Cost-benefit analysis of ocular examination of patients with rosacea;Análise do custo-benefício da avaliação ocular de pacientes portadores de rosácea

Arquivos Brasileiros de Oftalmologia

Volumn 68, Issue 1, 2005, Pages 37-43

  De Oliveira Lima, Keila Barbosa ^a,b   De Sousa, Luciene Barbosa ^a   Santos, Namir Clementino ^a   De Nadai Barros, Jeison ^a   Antonio, Denise ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Acne rosacea; Cost benefit analysis; Eyelid diseases diagnosis; Meibomian glands; Vision tests economics

Indexed keywords

FLUORESCEIN; ROSE BENGAL;

ADULT; AGED; ARTICLE; BLEPHARITIS; CLINICAL ARTICLE; CONJUNCTIVA; COST BENEFIT ANALYSIS; DIAGNOSTIC PROCEDURE; EYE DISEASE; FEMALE; FOREIGN BODY; HEALTH CARE COST; HEALTH CARE DELIVERY; HUMAN; HYPEREMIA; IMPRESSION CYTOLOGY; MALE; MEIBOMIAN GLAND; PRURITUS; QUESTIONNAIRE; ROSACEA; SCHIRMER TEST; STAINING; TELANGIECTASIA; VISION TEST;

EID: 28244471620     PISSN: 00042749     EISSN: 16782925     Source Type: Journal    
DOI: 10.1590/s0004-27492005000100007     Document Type: Article

References (18)

1. Browning DJ, Proia AD. Ocular rosacea. Surv Ophthalmol. 1986;31(3):145-58. Review.
2. Marks R. Concepts in the pathogenesis of rosacea. Br J Dermatol. 1968;80 (3):170-7.
3. Akpek EK, Merchant A, Pinar V, Foster CS. Ocular rosacea: patient characteristics and follow-up. Ophthalmology. 1997;104(11):1863-7.
4. Arffa RC. Grayson's diseases of the cornea. 4th ed. St Louis: Mosby: 1997.
5. Zengin N, Tol H, Gündüz K, Okudan S, Balevi S, Endogru H. Meibomian gland dysfunction and tear film abnormalities in rosacea. Cornea. 1995;14(2):144-6.
6. Tanzi EL, Weiberg JM. The ocular manifestations of rosacea. Cutis. 2001;68 (2):112-4. Review.
7. Zug KA, Palay DA, Rock B. Dermatologicf diagnosis and treatment of itchy red eyelids. Surv Ophthalmol. 1996;40(4):293-306. Review.
8. Kligman AM. Ocular rosacea. Current concepts and therapy. Arch Dermatol. 1997;133(1):89-90.
9. Gudmundsen KJ, O'Donnell BF, Powell FC. Schirmer testing for dry eyes in patients with rosacea. J Am Acad Dermatol. 1992;26(2 Pt 1):211-4.
10. Pflugfelder SC, Tseng SC, Yoshino K, Monroy D, Felix C, Reis BL. Correlation of goblet cell density and mucosal ephitelial membrane mucin expression with rose bengal staining in patients with ocular irritation. Ophthalmology. 1997;104(2):223-35.
11. Nelson JD. Cellulose acetate impressions of the ocular surface. Dry eyes states. Arch Ophthalmol. 1983;101(12):1869-72.
12. Barros JN, Mascaro VLDM, Gomes JAP, Freitas D, Lima ALH. Citologia de impressão de superfície ocular: técnica de exame e de coloração. Arq Bras Oftalmol. 2001;64(2):127-31.
13. Quarterman MJ, Johnson DW, Abele DC, Lesher JL Jr, Hull DS, Davis LS. Ocular rosacea. Signs, symptoms, and tear studies before and after treatment with doxyeycline. Arch Dermatol. 1997;133(1):49-54.
14. Berg M, Lidén S. An epidemiological study of rosacea. Acta Derm Venereol. 1989;69(5):419-23.
15. Hoang-Xuan T, Rodriguez A, Zaltas MM, Rice BA, Foster CS. Ocular rosacea. A histologic and immunopathologic study. Ophthalmology. 1990;97(11):1468-75.
16. Macri A, Pflugfelder S. Correlation of the Schirmer 1 and fluorescein clearance test with the severity of corneal epithelial and eyelid disease. Arch Ophthalmol. 2000;118(12):1632-8.
17. Hope-Ross MW, Chell PB, Kervick GN, McDonnell PJ. Recurrent corneal erosion: clinical features. Eye. 1994;8(Pt 4):373-7.
18. Pflugfelder SC, Tseng SC, Sanabria O, Kell H, Garcia CG, Felix C, et al. Evaluation of subjective assessments and objective diagnostic tests for diagnosing tear-film disorders known to cause ocular irritation. Cornea. 1998:17(1):38-56.